PSMA B ligand - Shuttle Diagnostics
Alternative Names: PSMA-B-LigandLatest Information Update: 31 May 2024
At a glance
- Originator Shuttle Pharmaceuticals
- Developer Shuttle Diagnostics
- Class Antineoplastics; Diagnostic agents; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Prostate cancer